A thermostable mRNA vaccine against COVID-19

Zhang, Na-Na, Li, Xiao-Feng, Deng, Yong-Qiang, Zhao, Hui, Huang, Yi-Jiao, Yang, Guan, Huang, Wei-Jin, Gao, Peng +23 more·2020·Cell
DOI 10.1016/j.cell.2020.07.024

Cited by (670)

Items 601–670 of 670

  1. Heterogeneity in protocols for bronchoalveolar lavage & sub-genomic RNA evaluation in non-human primate studies of SARS-CoV-2 vaccine candidates’ evaluation
    Sanjay Kumar · 2021 · The Indian Journal of Medical Research
  2. The Techniques Used on the Development of COVID-19 Vaccine
    Jiatong Su · 2021 · E3S Web of Conferences
  3. Engineering Biomimetic Nanoparticles for Biomedical Applications
    Emine Sumeyra Turali Emre · 2021 · Deep Blue (University of Michigan)
  4. Insights into Molecular Mechanisms Underlying COVID-19 Pathogenesis and Potential Therapeutics
    Shravanthi Ravula, Sai Charitha Mullaguri, Sravani Akula, Ravalika Silveri, Rama Krishna Kancha · 2021 · Indian Journal of Pharmaceutical Sciences
  5. Public Health Guidance and Research Strategies to Combat the Next COVID Pandemic
    Reed Cooper, Mark Crowder · 2021 · Journal of Student Research
  6. Novel Strategies of Immunization against COVID-19
    Aparajita Sen, Sunita Aggarwal, Shalini Sehgal, Nitika Nagpal, Aayushi, Anushka Joshi, Pranjal Saini, Radhika Chawla · 2022 · Journal of Pure and Applied Microbiology
  7. Estudos sobre aspectos da resposta imune em infecções virais incluindo: proteção cruzada entre os vírus Chikungunya e Mayaro; análise de epítopos antigênicos da proteína E do vírus Zika; e avaliação da resposta à vacina inativada de SARS-CoV-2
    Marcílio Jorge Fumagalli · 2022
  8. Biotechnology strategies for the development of novel therapeutics and vaccines against the novel COVID-19 pandemic
    Kenneth H. Lundstrom · 2022 · Elsevier eBooks
  9. The Latest Advances in the Development of Vaccines and Drugs for COVID-19
    Yunman M. Gu, Yingying He, Yutong Li · 2022 · 2022 International Conference on Biotechnology, Life Science and Medical Engineering (BLSME 2022)
  10. Analyzing Toxicology Reports of the COVID-19 Vaccine
    Eesha Lingala, Rajagopal Appavu, Jothsna Kethar · 2021 · Journal of Student Research
  11. Non-invasive transdermal delivery of biomacromolecules with fluorocarbon-modified chitosan for melanoma immunotherapy and transdermal vaccines
    Wenjun Zhu, Ting Wei, Qiutong Jin · 2022 · Research Square
  12. Research on the Influence of COVID-19 on the Fluctuation of China Household Electrical Appliances’ Index in the Context of Economic Globalization
    Yang Jing-Xu · 2022 · Journal of Economics Management and Trade
  13. Identification of the Metaphyseal Skeletal Stem Cell
    Guan Yang, Qi He, Xiaoxiao Guo et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  14. Assessment of the post-SARS-CoV-2 vaccination response depending on the epidemiological status, demographic parameters and levels of selected cytokines in medical personnel
    Zbigniew Bartuzi, Tomasz Rosada, Natalia Ukleja-Sokołowska, Katarzyna Napiórkowska-Baran, Kinga Lis, Magdalena Żbikowska-Götz, Wojciech Kowalczyk, Ewa Szynkiewicz, Ewa Alska, Łukasz Cała · 2022 · Advances in Dermatology and Allergology
  15. Inhalable SARS-CoV-2 vaccines for single-dose dry-powder aerosol immunization and orchestrated mucosal/systemic immune responses
    Tong Ye, Zhouguang Jiao, Xin Li, Zhanlong He, Yanyan Li, Fengmei Yang, Xin Zhao, Youchun Wang, Weijin Huang, Meng Hua Qin et al. · 2022 · Research Square
  16. "SARS-CoV-2 Antibodies and Immunity: Still to Explore for COVID-19"
    Ashok K. Chakraborty · 2022 · Biomedical Journal of Scientific & Technical Research
  17. A REVIEW ON ADVANCES AND CHALLENGES IN DEVELOPMENT OF MRNA-BASED VACCINES
    Sahar Akbarizadeh-Khajeh, Ali Farhadi Biregani, Abbas Doosti · 2022 · Studies in Medical Sciences
  18. La Ciencia detrás de la vacunas contra SARS CoV-2
    E. J. Gutiérrez-Ruiz, Roger Iván Rodríguez‐Vivas, J.A. Rosado-Aguilar · 2022 · Bioagrociencias
  19. Adverse cardiac events following mRNA COVID-19 vaccination: A systematic review and meta-analysis
    Eka Arum Cahyaning Putri, Misbakhul Munir, Hayuris Kinandita Setiawan, Lilik Herawati, Gadis Meinar Sari, Citrawati Dyah Kencono Wungu, Hendri Susilo, Henry Sutanto · 2022 · Journal of Pharmacy & Pharmacognosy Research
  20. Universal access to vaccines in post-COVID bioeconomy: Redesign for variants of concern and patent protection
    Cristina de Albuquerque Possas, Adelaide María de Souza Antunes, Alessandra Moreira de Oliveira, Suzanne de Oliveira Rodrigues Schumacher, Akira Homma · 2023 · Elsevier eBooks
  21. Application of nucleic acid-encoded antibodies in prevention and treatment of emerging viral infectious diseases
    Suo-Qun Zhao, Hang Chi, Cheng‐Feng Qin, Yong‐Qiang Deng · 2023 · Chinese Science Bulletin (Chinese Version)
  22. Lipid nanoparticle-mediated delivery of mRNA for IL-21 achieves clearance of hepatitis B virus in mouse models
    Zhongliang Shen, Shenyan Zhang, Nannan Liu, Qirong Jiang, Zixiang Gao, Weiju Hao, Qiang Deng, Jing Liu, Jiming Zhang, Youhua Xie · 2023
  23. Warm Covid Vaccine
    Krish Rao, Rajagopal Appavu · 2022 · Journal of Student Research
  24. Research Advances in SARS-Cov-2 Vaccination of Bell’s Palsy
    怡 余 · 2023 · Advances in Clinical Medicine
  25. Applications of Uniform Particles in Vaccine Formulations
    Guanghui Ma · 2023
  26. Inhalable SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization
    Tong Ye, Zhouguang Jiao, Xin Li et al. · 2023 · Research Square
  27. Research progress and prospects of standardized testing and assessment for nanobiomaterials
    Ying Liu, Meiyu Wu, Yi Liu, Jie Gao, Xiaoping Wang, Kuan Chen, Hairuo Wen, Liang Chen, Anliang Shao, Baiquan Xiao et al. · 2023 · Chinese Science Bulletin (Chinese Version)
  28. Efficacy, Immunogenicity and Safety of a Monovalent Omicron BA∙4/5 mRNA Vaccine (ABO1020) Given as Heterologous Booster in Adults: A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial
    Suad Hannawi, Ralph Elvi Villalobos, Erlina Burhan, Ma. Dovie Lallaine Borra, Rakesh Kumar Gupta, Grace P. Aquitania, Blake Warren Ang, Gelza Mae A Zabat, Camilo C. Roa, Jr., Loreta Zoleta De Jesus et al. · 2024 · SSRN Electronic Journal
  29. Construction and application of a technical platform for determining cell cycle- and autophagy-associated cellular accumulation of lipid-based nanoparticles
    Yisha Wang, Gan Luo, Haiyang Wang, Yue Zheng, Xiao Xu, Wenbin Zhou, J.Z. Lin, B.Y. Chen, Yifeng Jin, Meihua Sui · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  30. DESENVOLVIMENTO DE VACINAS CONTRA DOENÇAS INFECCIOSAS EMERGENTES: DESAFIOS E PERSPECTIVAS FUTURAS
    Ina Iara Lopes Lucena Guerra Silva, Ingridy Tayane Gonçalves Pires Fernandes, Márcia Zotti Justo Ferreira · 2024 · Revista Ibero-Americana de Humanidades, Ciências e Educação
  31. Advancing mRNA technology for high-quality development of biopharmaceutical industry
    Cheng‐Feng Qin, Qihui Wang, Fu Gao · 2024 · Chinese Science Bulletin (Chinese Version)
  32. Rapid preparation and characterization of pan-sarbecovirus mRNA vaccine candidates based on the receptor binding domain
    Mei Wu, Tian-Shu Cao, Xiao-Chuan Xiong · 2024 · Virologica Sinica
  33. Advances in the development of therapeutic mRNA vaccines for cancer therapy
    Kexin Deng, Xiaobin Li, Wanwan Liu, Junyu Liu, Runming Wang, Yandong Yin, Can Yang Zhang · 2024 · Chinese Science Bulletin (Chinese Version)
  34. SARS-CoV-2 spike protein in infectivity
    Alaa Muayad Altaie, Rania Hamdy, Mohamed Ibrahim Husseiny, Sameh S. M. Soliman · 2025 · Elsevier eBooks
  35. Neue Methoden am Übergang von der Forschung in die Routinediagnostik
    Argyris Papantonis, Stephan Rogalla, Christian Dullin, Frauke Alves, Hanibal Bohnenberger · 2025 · Die Pathologie
  36. mRNA Vaccines: Unlocking Potential, Exploring Applications, and Envisioning Future Horizons
    Gaurav Mishra, Sunny Rathee, Munish Garg, Umesh Kumar Patil · 2025 · Current Drug Delivery
  37. Nanotherapeutics in COVID-19 and associated pulmonary infections
    Zahanat Muneer Mir, Parul Thakur, Rimpi Arora, Navjot Kanwar, Ashish Baldi · 2025 · Elsevier eBooks
  38. Pharmaceutical perspectives on oligonucleotide therapeutics and delivery systems
    Dalton W. Staller, Flobater I. Gawargi, Sanjali S. Panigrahi, Paras Kumar Mishra, Ram I. Mahato · 2025 · Pharmacological Reviews
  39. AI and nanotechnology integration and future pandemic prediction
    Fadilla ‘Atyka Nor Rashid, Marizuana Mat Daud, Anbia Adam, Siaw‐Hong Liew, Fazlina Mohd Ali, Nazhatul Hafizah Kamarudin · 2025 · Elsevier eBooks
  40. Bivalent fusion protein vaccine induces protective immunity against SARS-CoV-2 and Staphylococcus aureus
    Menghan Ma, Jintao Zou, Xiaoqiang Zeng · 2025 · Vaccine
  41. Immunogenicity, Efficacy and Twelve-Month Storage Stability Studies of a Lyophilized Rabies mRNA Vaccine
    Chen Chen, Dandan Ling, Kai Ji, Liang Dao Tang, Xiaojing Zhang, Xishan Lu, Xuemei Leng, Changyao Tan, Hongchao Wu, Wenqiang Pang et al. · 2025 · Vaccines
  42. What are HeLa cells? A cancer biologist explains
    Iván Martínez · 2022
  43. Environmental study analyzing the knowledge of vaccinated patients about complications after vaccination against COVID-19: A preliminary report
    Maria Stachura, Adriana Biela, Zuzanna Puszczewicz, Julia Wypyszyńska, Natalia Zaboklicka, Tomasz Męcik-Kronenberg · 2025 · Annales Academiae Medicae Silesiensis
  44. The Three Acts of Pandemic Governance: A Comparison Between France, Germany, Italy, and the UK
    Bartholomew Alexander Konechni, Ettore Recchi · 2025 · Springer eBooks
  45. Viral protease-Initiated Pyroptosis Activator mRNA therapy as a Universal Antiviral Strategy
    Lin Li, Xiuli Yan, Haoyang Wang, Hangyu Zhou, Yuyan Li, Jian Li, Rongrong Zhang, Lu Lv, Xing‐Yao Huang, Hao Du et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  46. Additional file 1 of A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants
    Lee, I-Jung, Sun, Cheng-Pu, Wu, Ping-Yi, Lan, Yu-Hua, Wang, I-Hsuan, Liu, Wen-Chun, Joyce Pei‐Yi Yuan, Chang, Yu-Wei, Tseng, Sheng-Che, Tsung, Szu-I et al. · 2022 · Figshare
  47. Direct Cytoplasmic Transcription and Trimeric RBD Design Synergize to Enhance DNA Vaccine Potency Against SARS-CoV-2
    Yunju Nam, Sang Chul Shin, Sang Won Cho, Hyung Jun Ahn · 2026 · Pharmaceutics
  48. MRNA-LNP Vaccines Targeting a UreB199-338 Epitope Elicit Protective Immunity Against Helicobacter pylori Infection
    Ying Zhang, Leyang Zhao, Xiaoya Li, Tianshuo Yang, Yuqi Zhao, K. Li, Jianing Zhao, Yueping Liu, Lianmei Zhao · 2026 · Research Square
  49. Status and outlook of mRNA therapeutics for viral diseases
    Qiuwei Pan, Wenshi Wang, Janssen Hl, Zifu Zhong · 2026 · EMBO Molecular Medicine
  50. Testicular mRNA‐LNP Delivery: A Novel Therapy for Genetic Spermatogenic Disorders
    Chenwang Zhang, Nan Liang, Wenbo Li, Shuai Xu, Peng Li, Wanze Ni, Na Li, Sha Han, Ningjing Ou, Haowei Bai et al. · 2026 · Advanced Science
  51. Research progress on hepatitis A vaccine
    RUAN Ruotong, Ma Qingqing, Qi Chen · 2026 · Chinese Science Bulletin (Chinese Version)
  52. Incorporation of a Human-Derived CU-Rich Element in the 3′ UTR Improves Synthetic mRNA Stability and Expression In Vivo
    Jia Tang, Meng Li, Baiyao Liu, Chuantao Wu, Fan Dai, Hanzhi Kang, Kai He, Wenxue Zhao · 2026 · ACS Synthetic Biology
  53. Circ_0057105 promotes intrahepatic cholangiocarcinoma progression by sponging miR-1290 and regulating the MDM2/P53 pathway
    Taiyang Chen, Yangyang Wang, Chenxi Xie et al. · 2026 · Cellular Signalling
  54. Intramuscular administration of LNP-mRNA therapeutics
    Hamid Tanzadehpanah, Hanie Mahaki, Mohsen Sheykhasan, Seyed Sajjad Alavi-Kakhki, Hossein Shahdadi Sardou, Zahra Mobarezi, Amir Hossein Esfandiari, Zahra Meshkat, Hamed Afkhami, Hamed Manoochehri · 2026 · Elsevier eBooks
  55. RNASTOP: A Deep Learning Framework for mRNA Chemical Stability Prediction and Optimization
    Shenggeng Lin, Junwei Chen, Heqi Sun, Yufang Zhang, Wenyi Yang, Hong Tan, Dong‐Qing Wei, Qinghua Jiang, Yi Xiong · 2026 · Genomics Proteomics & Bioinformatics
  56. Research progress in ionizable cationic lipids in mRNA delivery: from synthetic strategies to applications
    Xinwei Zhang, Yuqin Liao, Xuechuan Hong, Yuling Xiao, Xiaodong Zeng · 2026 · Science China Chemistry
  57. Biocompatible nanosystems for innovative applications of small therapeutic molecules
    Ilaria Andreana · 2022
  58. mRNA-Based Therapies for Cartilage Regeneration: A Literature Review
    Hafiz Muhammad Hamza, Shazaf Masood Sidhu, Naser Khan Ghafoor Jamal · 2026 · Journal of Rawalpindi Medical College
  59. Cationic nanolipoplexes for high-performance mRNA transfection at the nasal mucosa
    Piroonrat Dechbumroong, Sarawut Lapmanee, Wisawat Keaswejjareansuk, Thunyatorn Yimsoo, Worapapar Treesuppharat, Apipu Ariyachayut, Xing-Jie Liang, Katawut Namdee, Mengliang Zhu · 2026 · European Journal of Pharmaceutics and Biopharmaceutics
  60. Rational development of an mRNA antibody cocktail with extended therapeutic window against ricin intoxication
    Mei Wu, Xi Luo, Pei‐Yu Jiang, Qian Xu, Fei-Xue Du, Xiang Chen, Yang Feng-qin, Zijin Cui, Yu-Yan Li, Jie-Yu Chen et al. · 2026 · Applied Microbiology and Biotechnology
  61. Bacterial mRNA Vaccines: Programming Immunity Against Antimicrobial Resistance
    Rui Liao, LUO Mingxing, Fating Yang, Lifeng Xu, Jingjing Zhang, Wei Zhang, Shan Guan, Y M Zhang, Ping Luo, Ping Cheng et al. · 2026 · Drug Development Research
  62. Hydrophobic Tail and Linker Diversification of PEG‐Lipids Unlocks Precise Muscle Tropism of mRNA‐Lipid Nanoparticles
    Bingqian Ou, Xuying Tang, Sunxiang Qian, Bo Chen, Sisi Fang, Jinshuang Su, Xiaopeng Sheng, Jie Feng, Zhefan Yuan, Jing Zhang · 2026 · Small
  63. Nanotechnology-Mediated Delivery of Vaccines in COVID-19 Management
    Naga Malleswara Rao Nakka, Hari Krishnareddy Rachamala, Satish Babu Nakka, Avirup Chakraborty, Ramcharan Singh Angom · 2026 · Nanomedicine and nanotoxicology
  64. Design and preclinical evaluation of a multi-epitope circular RNA vaccine targeting the spike protein of canine coronavirus genotype II
    Xiaoyu Zhang, Lingli Wang, Wenna He, Zeheng Ren, Chengguang Zhang, Ming Zhou, Jiawu Wan, Jianqing Zhao, Ling Zhao · 2026 · Veterinary Microbiology
  65. Therapeutic mRNA vaccines for lung cancer: reshaping the tumor microenvironment to enhance anti-tumor immunity
    Hao Wu, Ruiqi Weng, Siyi Gu, Jiyuan Wang, Xiaoyan Ma, Jiaxuan Li, Xiaotian Tie, Chongmin Huang, Keda Chen · 2026 · Frontiers in Immunology
  66. Advanced Materials for Biologics Delivery to Brain Tumors
    Yuran Feng, Yuxue Cao, Maria Kavallaris, Taskeen Iqbal Janjua, Amirali Popat · 2026 · Advanced Materials
  67. mRNA Therapeutics Beyond Infectious Diseases: Expanding Therapeutic Applications and Future Perspectives
    Gedion Mengistu · 2026 · Immunity Inflammation and Disease
  68. VIDA: A programmable gasdermin-mediated strategy to broaden mRNA therapeutics
    Yi-Jiao Huang, Cheng‐Feng Qin · 2026 · Molecular Therapy Oncology
  69. mRNA lipid nanoparticle vaccines: current status, challenges and future prospects
    吴志能, Jinghu Lou, Yi Cheng, Meng Li, Zengming Wang, Nan Liu, Xiang Gao, Aiping Zheng, Hui Zhang · 2026 · Molecular Biomedicine
  70. IL7R mRNA therapy enhances antitumor T cell immunity and suppresses tumor growth in preclinical tumor models
    Adeel ur Rehman, Muhammad Asad-ur-Rehman Khan, Aleena Akhtar, Qianshan Qin, X. X. Zhang, Muhammad Arif Asghar, Dandan Ling, Pei Wang, Ying Luo, Zhihuai Wang et al. · 2026 · Journal for ImmunoTherapy of Cancer